Results 121 to 130 of about 9,362 (180)

Glucosylceramide regulates depression through activating peroxisome proliferator-activated receptor gamma in dorsal striatum. [PDF]

Theranostics
Jiang L, He Y, Liu H, Zhang D, Dai Y, Bu Q, Shi Q, Duan H, Zhao Y, Li S, Han S, Zhou Y, Zhao Y, Qin F, Chen Y, Wang L, Li H, Liu C, Qin M, Kuang W, Zhang N, Zhao Y, Cen X.   +22 more
europepmc   +1 more source

Resolving versus non-resolving sphingolipid dynamics during macrophage activation: a time-resolved metabolic analysis. [PDF]

J Lipid Res
Chiappa NF, Lal N, Botchwey EA.
europepmc   +1 more source

Flaxseed feeding enriches plasmalogens and glycosphingolipids and alters the esterification site of PUFAs in egg yolk phospholipids based on lipidomics analysis. [PDF]

Food Chem X
Wang Y, Cheng L, Zhang M, Ma Y, Dong L, Li Y, Fang B.   +6 more
europepmc   +1 more source

Glucosylsphingosine (Lyso-Gb1) Dynamics in Untreated States in Gaucher Disease. [PDF]

Int J Mol Sci
Dinur T, Bauer P, Schroeder S, Kramp G, Beetz C, Becker-Cohen M, Istaiti M, Frydman D, Shulman E, Zimran A, Revel-Vilk S.   +10 more
europepmc   +1 more source

Real-World Effectiveness and Safety of Eliglustat in Adult Patients with Gaucher Disease Type 1: A Multicenter Retrospective Study in China. [PDF]

J Clin Med
Zhou Y, Hao Z, Zhuang Q, Han B.
europepmc   +1 more source

Skin lamellar bodies: a unique set of lysosome-related organelles. [PDF]

Front Cell Dev Biol
Mahanty S.
europepmc   +1 more source

Safety and Efficacy of Ambroxol Therapy in Polish Patients with Gaucher Disease. [PDF]

Life (Basel)
Lipiński P, Rokicki D, Chwiałkowska K, Ciborowski M, Godzień J, Jezela-Stanek A, Korotko U, Kwaśniewski M, Niemira M, Szymańska-Rożek P, Syczewska M, Tylki-Szymańska A.   +11 more
europepmc   +1 more source

High-resolution sphingolipid analysis in vitro using LC-qToF MS. [PDF]

Methods Enzymol
Chitkara S, Atilla-Gokcumen GE.
europepmc   +1 more source

Multi-omics insights into GBA1-associated Parkinson's disease: interplay of genomics, transcriptomics, proteomics, and lipidomics. [PDF]

Mol Neurodegener
Ni Y, Cai H, Shao Y, Le W.
europepmc   +1 more source

Increased Lyso-Gb1 Levels in an Obese Splenectomized Gaucher Disease Type 1 Patient Treated with Eliglustat: Unacknowledged Poor Compliance or Underlying Factors. [PDF]

Metabolites
Maines E, Franceschi R, Luppi G, Marchi G, Piccoli G, Vitturi N, Soffiati M, Campomori A, Urru SAM.   +8 more
europepmc   +1 more source